Page last updated: 2024-09-03

neurotensin (8-13) and neuropeptide y

neurotensin (8-13) has been researched along with neuropeptide y in 1 studies

Compound Research Comparison

Studies
(neurotensin (8-13))
Trials
(neurotensin (8-13))
Recent Studies (post-2010)
(neurotensin (8-13))
Studies
(neuropeptide y)
Trials
(neuropeptide y)
Recent Studies (post-2010) (neuropeptide y)
6601010,6631522,269

Protein Interaction Comparison

ProteinTaxonomyneurotensin (8-13) (IC50)neuropeptide y (IC50)
Neuropeptide Y receptor type 1Homo sapiens (human)0.0014
Neuropeptide Y receptor type 2Homo sapiens (human)0.0003

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernhardt, G; Biselli, S; Buschauer, A; Cabrele, C; Einsiedel, J; Gmeiner, P; Hübner, H; Keller, M; Kuhn, KK; Mollereau, C; Svobodová, J; Vanderheyden, PM; Wifling, D1

Other Studies

1 other study(ies) available for neurotensin (8-13) and neuropeptide y

ArticleYear
Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.
    Journal of medicinal chemistry, 2016, Mar-10, Volume: 59, Issue:5

    Topics: Angiotensin II; Arginine; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Neuropeptide Y; Neurotensin; Oligopeptides; Peptide Fragments; Receptors, Angiotensin; Receptors, Neuropeptide; Receptors, Neurotensin; Structure-Activity Relationship

2016